IN THE GASTROINTESTINAL (GI) mucosa, epithelial cell migration and proliferation play fundamental roles in homeostatic turnover, restoration of tissue integrity after injury, and pathogenesis of intestinal disorders, including inflammatory bowel diseases and carcinogenesis. Within minutes of epithelial injury, cells adjacent to a wound extend lamellipodia and migrate over the denuded area to reestablish epithelial continuity, a rapid process of wound repair known as restitution (17, 29, 33) . Subsequently, the cells enter into DNA synthesis and divide to replace cells lost in injury and restore the normal mucosal surface (33) . Despite their importance, the intracellular signal transduction mechanisms and cross-talk interactions controlling the proliferation and migration of intestinal epithelial cells remain incompletely understood.
Protein kinase D1 (PKD1) is the founding member of a new protein kinase family within the Ca 2ϩ /calmodulin-dependent protein kinase group (47) . PKD1 can be activated within intact cells by multiple stimuli, including G protein-coupled receptor agonists, growth factors, and oxidative stress (46, 47) . Rapid activation is mediated by protein kinase C (PKC)-mediated phosphorylation of Ser 744 and Ser 748 in the PKD1 activation loop (residue number corresponding to the mouse PKD1). PKD1 catalytic activation within cells leads to its rapid autophosphorylation at Ser 916 (27, 50 -52) . PKC-dependent PKD1 activation is followed by a late, PKC-independent phase of activation induced by G q -coupled receptor agonists (18, 50, 51) . Accumulating evidence demonstrates that the PKD family plays an important role in several cellular processes and activities, including signal transduction (1, 52, 53, 57, 60) , chromatin organization (25) , Golgi function (23, 34) , gene expression (7, 28, 55) , immune regulation (25) , and cell survival, adhesion, motility, differentiation, DNA synthesis, and proliferation (reviewed in Refs. 46 and 47) .
The nontransformed rat intestinal epithelial cell lines IEC-6 and IEC-18 (36, 37) , which originate from small intestinal crypt cells, have provided a model system to examine migration, proliferation, and differentiation (3-6, 8, 9, 14, 21, 48, 54, 56, 62) . We demonstrated that PKD1 is rapidly activated in these cells by a variety of mitogenic stimuli (3, 6, 44) , and subsequent results revealed that PKD1 activation plays a critical role in mediating DNA synthesis and cell proliferation in these cells (51) . Furthermore, transgenic mice that express elevated PKD1 protein in intestinal cells display a marked increase in DNA-synthesizing cells in their intestinal crypts and a significant increase in the length and total number of cells per crypt (51) . Collectively, these results support the notion that PKD1 signaling is a novel element in the pathways leading to proliferation of intestinal epithelial cells in vitro and in vivo. In contrast, the contribution of PKD1 signaling to intestinal epithelial cell migration remains poorly understood. Specifically, the impact of the breakdown of cell-cell contacts by wounding on PKD1 activity has not been examined in any cell type, and the role of PKD1 activity in the migration of intestinal epithelial cells is unknown.
The experiments presented here were designed to elucidate the role of PKD1 signaling in intestinal epithelial cell migration induced in response to wounding. We demonstrate, for the first time, that wounding monolayer cultures of these cells induces rapid PKD1 activation in the cells located immediately adjacent to the wound edge. This finding implicates PKD1 signaling in the pathways leading to the initiation of cell migration and wound healing. In agreement with this hypothesis, treatment with selective inhibitors of the PKD family or small interfering RNA (siRNA)-mediated depletion of PKD1 expression markedly reduced wound-induced migration of IEC-18 and IEC-6 cells. These results demonstrate that PKD1 activation is one of the early events initiated by wounding a monolayer of intestinal epithelial cells and indicate that PKD1 signaling is required for the migration of these cells into the denuded area of the cell monolayer. Furthermore, enterocyte migration was markedly increased in the PKD1 transgenic mice compared with nontransgenic littermates. Collectively, the results with cells and PKD1 transgenic mice demonstrate that PKD1 is a novel element that promotes migration in intestinal epithelial cells.
MATERIALS AND METHODS
Cell culture. Nontumorigenic crypt-derived intestinal epithelial IEC-18 and IEC-6 cells (36, 37) were purchased from American Type Culture Collection and maintained as described elsewhere (19, 20) . Briefly, cells were cultured in DMEM supplemented with 10% FBS and penicillin-streptomycin and kept at 37°C in a 10% CO 2 incubator. Stock cultures were subcultured every 3-4 days.
Wounding and migration assays. For one-dimensional migration assays, cells were plated onto 35-mm dishes with a removable insert (-Dish with culture insert, Ibidi, Applied Biophysics, Troy, NY). The insert consists of two wells separated by a 500-m-wide partition to which cells do not adhere. Before the experiment, cells were confluent and quiescent in serum-free DMEM, as shown by the fact that only a small proportion (ϳ10%) of the cells in the population are in the S phase of the cell cycle (4) . At the beginning of the experiment, the partition was removed, creating a 500-m-wide 7-mm-long cellfree gap that, in time, was filled with cells. Except for time 0 images, the cells were returned to the incubator and imaged at various times. Digital images of the time course of gap closure were taken with a digital camera (1,388 ϫ 1,048 pixel resolution, AxioCam MRm, Carl Zeiss Microscopy) attached to an inverted microscope (Axio Observer A1, Carl Zeiss Microscopy) with a ϫ10 phase lens. Images were analyzed with image-processing software (Axiovision 4.8.2, Carl Zeiss Microscopy). Gap closure was quantified by determining the mean distance of closure of the gap. This was done by measuring the area of the cell-free space, dividing by the length of the gap, and then subtracting this value from 500 m. At least four gap images were processed for each time point. In other cases, the cell monolayer was wounded by applying a razor blade to the dish and scraping perpendicular to the plane of the blade (40 mm long ϫ 6 -8 mm wide). Cells were then incubated in serum-free DMEM. After 16 h, experiments were terminated: cells were washed twice in PBS and then fixed in 10% buffered formalin phosphate at 25°C for 20 min. To measure cell migration, cells were stained with Wright-Giemsa (Sigma, St. Louis, MO) and observed under phase contrast with a ϫ10 lens (Plan-Neo, Carl Zeiss Microscopy) mounted on an upright microscope (Axioskop2, Carl Zeiss Microscopy). Images were collected with a highresolution digital camera and software (Spot, Diagnostic Instruments, Sterling Heights, MI) from five to eight representative wounded areas per condition. Migration was calculated as the number of cells moving across the cut boundary per 100 m of cut length.
For two-dimensional assays, cells were plated into Radius 24-well cell migration assay plates (Cell Biolabs, San Diego, CA). Each well contains a circular 680-m-diameter gel spot to which cells do not attach. Before the experiment, cells were confluent and quiescent. At the start of the experiment, the gel spot was removed within 5 min, and cells then populated the circular void space. Digital images of the gap closure were taken with a digital camera (1,388 ϫ 1,048 pixel resolution, AxioCam MRm) attached to a microscope (Axio Observer A1) with a ϫ10 phase lens. Images were analyzed with imageprocessing software (Axiovision 4.8.2).
Immunofluorescence. At various times after removal of the insert or scraping, cells were fixed with 4% paraformaldehyde, permeabilized with Triton X-100, and labeled with primary antibody to phosphorylated (Ser 916 ) PKD (1:1,000 dilution; catalog no. 2051, Cell Signaling Technology) overnight. This antibody recognizes predominantly PKD1, the major PKD family isoform in IEC-18 cells, although a signal from PKD2 can also be detected (51) . Then the cells were labeled with the secondary antibody Alexa Fluor 546 anti-rabbit (1:100 dilution; Molecular Probes, Carlsbad, CA) for 1.5 h. Images of the cells at the edge of the gap were taken by a digital camera (Pursuit, 2,048 ϫ 2,048 m pixel resolution with associated software, Spot version 4.7, Diagnostic Instruments). Images were analyzed by importation into image-processing software (LSM 510, Carl Zeiss Microscopy).
Fluorescent image quantification. For quantification of fluorescent label, the image-processing software was used to outline the area of a single row of cells parallel to the edge of the wound, and the average pixel intensity within that area was determined. Pixel intensities were background-corrected. Average background fluorescence from the area without cells was subtracted from the fluorescence in the cells. Several images from each wound at each time point were processed, so that Ն50 cells were tabulated within each row of cells.
F-actin stain. F-actin was labeled using fluorescent phalloidin (Alexa Fluor 488-phalloidin, Molecular Probes) prepared according to the manufacturer's protocol. Briefly, at 6 h after they were wounded, the cells were fixed in paraformaldehyde for 10 min, washed twice, incubated in staining solution for 20 min, and washed three times. Images were obtained as described above (see Immunofluorescence).
Immunoblotting and detection of PKD1 phosphorylation. Confluent IEC-18 cells were lysed in 2ϫ SDS-PAGE sample buffer (20 mM Tris·HCl, pH 6.8, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, and 10% glycerol) and boiled for 10 min. After SDS-PAGE, proteins were transferred to Immobilon-P membranes. The transfer was carried out at 100 V, 0.4 A at 4°C for 4 h using a Bio-Rad transfer apparatus. The transfer buffer consisted of 200 mM glycine, 25 mM Tris, 0.01% SDS, and 20% CH3OH. For detection of proteins, membranes were blocked using 5% nonfat dry milk in PBS (pH 7.2) and then incubated for Ն2 h with the desired antibodies diluted in PBS containing 3% nonfat dry milk. Primary antibodies bound to immunoreactive bands were visualized by enhanced chemiluminescence detection with horseradish peroxidase-conjugated anti-mouse, anti-rabbit antibody and a FUJI LAS-4000 Mini Luminescent Image Analyzer. Band intensities were quantitated using Multi Gauge version 3.0 software. The phosphospecific polyclonal antibodies pS916, pS744, and pS748 detect the phosphorylated state of residues Ser 916 , Ser 744 , and Ser 748 of PKD1.
Immunoprecipitation and in vitro kinase assay of PKD1. Confluent cultures of IEC-18 cells were injured by multiple parallel scrapes, washed, and lysed in 50 mM Tris·HCl, pH 7.6, 2 mM EGTA, 2 mM EDTA, 1 mM dithiothreitol, 10 g/ml aprotinin, 10 g/ml leupeptin, 1 mM 4-(2-aminoethyl)benzene sulfonyl fluoride, and 1% Triton X-100 (lysis buffer A). Cell lysates were clarified by centrifugation at 15,000 g for 10 min at 4°C. PKD1 was immunoprecipitated at 4°C for 2-4 h with the PKD1 (PKD1 C-20) antiserum (1 g/ml) raised against the COOH-terminal region of PKD1 (Santa Cruz Biotechnology, Santa Cruz, CA). The immune complexes were recovered using protein A coupled to agarose. The immune complexes were washed twice with lysis buffer and then twice with kinase buffer consisting of 30 mM Tris·HCl, pH 7.4, 10 mM MgCl 2, and 1 mM dithiothreitol.
Autophosphorylation reactions were initiated by combining 20 l of immune complexes with 5 l of a phosphorylation mixture containing 100 M [␥- 32 P]ATP (specific activity 300 -600 cpm/pmol) in kinase buffer. After incubation at 30°C for 10 min, the reactions were terminated by addition of 1 ml of ice-cold kinase buffer and placed on ice. Immune complexes were recovered by centrifugation, and the proteins were extracted for SDS-PAGE by addition of 2ϫ SDS-PAGE sample buffer (200 mM Tris·HCl, pH 6.8, 0.1 mM sodium orthovanadate, 2 mM EDTA, 6% SDS, 4% 2-mercaptoethanol, and 10% glycerol). Dried SDS-polyacrylamide gels were subjected to autoradiography to visualize radiolabeled protein bands.
siRNA transfection. The pooled siRNA duplexes were purchased from Dharmacon (Lafayette, CO) or Santa Cruz Biotechnology. PKD1 siRNA pools were designed to target the mRNA of mouse PKD1 (GenBank accession no. NM_008858) and consist of four different duplexes from Dharmacon [oligo1 (GAAGAGAUGUAGC-UAUUAAUU), oligo2 (GAAAGAGUGUUUGUUGUUAUU), oligo3 (CAUAAGAGAUGUGCAUUUAUU), and oligo4 (CAGCGAAUGU-AGUGUAUUAUU)] or three different duplexes from Santa Cruz Biotechnology [oligo1 (CUCUCUUCGUUCAUUCAUAt), oligo2 (GUGAGCAUUUCCGUUUCAAtt), and oligo3 (GAAGCCAUUGAUCUUAUCAtt)]. Two siRNA transfection methods were used. For one method, IEC-18 cells were plated at a density of 2 ϫ Intestinal epithelial cell migration. To assess the effect of PKD1 expression on intestinal epithelial cell migration, we used transgenic mice that express elevated PKD1 protein in the small intestine and colonic epithelium and control littermates. The generation of PKD1 transgenic mice is described elsewhere (51) . Overexpression of PKD1 in the ileum was verified using epithelial cells isolated sequentially along the crypt-villus axis by timed incubations in EDTA-PBS solutions (12, 24) . To measure the migration of intestinal epithelial cells in vivo, gender-and age-matched mice (5 PKD1 transgenic mice and 5 nontransgenic littermates), maintained as previously described (51), were injected intraperitoneally with the thymidine analog 5-bromo-2=-deoxyuridine (BrdU) at 100 g/g body wt. After 4 h (15), the mice were anesthetized with halothane and cardioperfused with PBS followed by 4% paraformaldehyde in PBS. Sections (4 m) of paraffinembedded ileal tissue were deparaffinized and stained for BrdU incorporation using a BrdU staining kit (BrdU In-Situ Detection Kit II 551321, BD Pharmingen) according to the manufacturer's instructions. Enterocyte migration was determined by measuring the distance from the bottom of the crypt to the foremost labeled enterocyte (2, 38) (see Fig. 10B ). At least 20 full-length, longitudinally cut crypts were used from each animal.
Statistical analysis. Values are means Ϯ SE. Differences between groups were analyzed with the unpaired Student's t-test.
RESULTS

Wounding of intestinal epithelial cells rapidly activates PKD1 phosphorylation in cells at the wound edge.
To determine whether endogenous PKD1 activation is an early event in response to wounding of the intestinal epithelial monolayer, we used confluent IEC-18 cells and immunofluorescence microscopy with an antibody that detects the phosphorylated state of PKD1 at Ser 916 , a well-established autophosphorylation site (27, 50 -52) . The antibody recognizes predominantly PKD1, the major PKD family isoform in IEC-18 cells, although a signal from PKD2 can also be detected (51) . The cultures were grown to confluence, washed, and transferred to serum-free medium before wounding was mimicked by removal of an insert that created a 500-m-wide 7-mm-long cell-free gap in the monolayer. Before wounding, IEC-18 cells contained little active PKD1, as indicated by the absence of detectable phosphospecific Ser 916 immunoreactivity (Fig. 1A) . Wounding for 3 min induced a striking increase in phosphospecific Ser 916 immunoreactivity in cells at the wound edge (Fig. 1B) . In contrast, total PKD1 immunoreactivity was not altered by wounding (Fig. 1, C and D) , indicating the specificity of the increase in Ser 916 immunoreactivity. To explore in more detail the effect of wounding on PKD1 activity within cells, we quantified the intensity of the phosphorylated state of PKD1 at Ser 916 in cells adjacent to the wound (1st row) and in the subsequent rows of cells away from the wound (Fig. 1E) . The salient feature of the results shown in Fig. 1B and quantified in Fig. 1E is that PKD1 activation in response to wounding occurred exclusively in the cells at the edge of the wound. Similar PKD1 activation in the cells at the edge of the wound was obtained when wounding was performed by scraping, rather than by removal of an insert (data not shown). In contrast, the intensity of total PKD1 fluorescence in cells adjacent to the wound (1st row) was identical to the intensity of fluorescence in the subsequent rows of cells away from the wound (Fig. 1F) .
Next, we determined the kinetics of PKD1 activation in response to wounding monolayers of IEC-18 cells. An increase in the phosphorylated state of PKD1 at Ser 916 in the cells adjacent to the wound was detectable as early as 45 s after wounding, reached a maximum after 1.5-3 min, and persisted for Ն15 min (Fig. 2) . Thus, PKD1 activation was a rapid consequence of wounding monolayers of IEC-18 cells.
To corroborate that the increase in the phosphorylated state of PKD1 at Ser 916 in response to wounding reflects rapid PKD1 catalytic activation in intestinal epithelial cells, we also used in vitro kinase assays after immunoprecipitation. To maximize the number of cells at the edge of a wound, cell monolayers were injured by multiple parallel scrapes. As shown in Fig. 3 detected in the cells at the edge of the gap. To test this hypothesis, we used the recently identified preferential PKD family inhibitors kb NB 142-70 and CRT0066101 (16, 22) . To verify the effectiveness of these inhibitors in IEC-18 cells, monolayers of these cells were treated with increasing concentrations of kb NB 142-70 or CRT0066101 and then stimulated with the G q -coupled receptor agonist angiotensin II, a potent inducer of PKD1 activation. Lysates of these cells were used to determine the phosphorylation of PKD1 at Ser 744 , Ser 748 , and Ser 916 using specific antibodies that detect the phosphorylated state of these residues (18, 58) . As shown in Fig. 4 , treatment of IEC-18 cells with kb NB 142-70 or CRT0066101 prevented PKD1 phosphorylation at Ser 748 and Ser 916 in a dose-dependent manner, consistent with the notion that these sites are autophosphorylated by PKD1 (18, 50, 59) . In contrast, phosphorylation of Ser 744 , the primary site targeted by novel PKCs (40, 59), was not affected by CRT0066101 or kb NB 142-70, corroborating the specificity of these inhibitors for PKD1 in intestinal epithelial cells.
Having verified the potency and specificity of kb NB 142-70 and CRT0066101 in IEC-18 cells, we next determined the effect of these inhibitors on the increase in phosphospecific Ser 916 immunoreactivity in the cells at the wound edge. As shown in Fig. 5 , the increase in PKD1 autophosphorylation at Ser 916 was abrogated by prior exposure of the monolayer to 2 M kb NB 142-70 or 2.5 M CRT0066101, concentrations that prevented PKD1 autophosphorylation in IEC-18 cells. These results support the notion that wounding induces rapid PKD1 activation, leading to its autophosphorylation at Ser 916 . Wound-induced PKD1 activation was not confined to IEC-18 cells. A rapid increase in PKD1 autophosphorylation that was prevented by prior treatment with 2 M kb NB 142-70 was also elicited by wounding monolayer cultures of nontumorigenic crypt-derived IEC-6 cells (Fig. 6 ). These results with preferential inhibitors of PKD family activity substantiate the conclusion that PKD1 activation is one of the earliest events initiated by wounding in intestinal epithelial cells.
PKD family inhibitors kb NB 142-70 and CRT0066101 prevent wound-induced migration of intestinal epithelial cells.
The cells immediately adjacent to the wound are the cells that move to occupy the empty area and, consequently, are of special significance in initiating the process of repair. Our results demonstrating rapid PKD1 activation in the intestinal epithelial cells at the edge of the wound not only identified a novel stimulus in PKD1 regulation but also prompted us to hypothesize that PKD1 signaling promotes the migration of intestinal epithelial cells into the denuded area of the monolayer. To test this hypothesis, we determined whether inhibition of PKD family activity with novel PKD inhibitors interferes with the ability of IEC-18 or IEC-6 cells to migrate into the wound and repopulate the denuded area of the monolayer. The cultures were grown to confluence, washed twice, and transferred to serum-free medium in the absence or presence of the selective PKD family inhibitor kb NB 142-70 for 1 h before removal of an insert that created a cell-free gap in the monolayer. Then cells were imaged at 6 and 12 h, and gap closure was measured off-line to determine the rate of cell migration. Treatment with kb NB 142-70 (2.5 M) strikingly reduced the ability of IEC-18 cells to migrate into the denuded area of the wound, measured 6 or 12 h after the creation of the gap in the monolayer (Fig. 7) . Using a two-dimensional assay, we also examined the role of PKD1 in wound-induced migration of IEC-18 cells. As shown in Fig. 7 , treatment with kb NB 142-70 markedly reduced the ability of the cells to close a two-dimensional circular gap.
Cell migration is a multistep process involving the formation of membrane protrusions, establishment of cell polarization characterized by rearward positioning of the nucleus, adhesion to the substratum, cell body translocation, and rear retraction (45) . In agreement with previous results (19) , many IEC-18 cells at the margin of the wound display broad cell protrusions (lamellipodia) oriented toward the denuded area of the wound and the nucleus in a rear position (Fig. 8A) . Treatment with kb NB 142-70, at a concentration that abolished wound-induced PKD1 activation, abrogated the rearward positioning of the nucleus (Fig. 8B) . To quantify nuclear repositioning and document the inhibition of this process by kb NB 142-70 in the cells at the edge of the wound, we measured the distance from the nucleus to the trailing edge of the cell and the length of the whole cell (a and b, respectively, in Fig. 8C ) and calculated an index (0.5b/a) that reflects the asymmetric position of the nucleus in migrating cells (asymmetry index). As shown in Fig. 8C , treatment with kb NB 142-70 abrogated the marked increase in nuclear repositioning in migrating IEC-18 cells, as demonstrated by the sharply reduced asymmetry index.
Many IEC-18 cells at the margin of the wound also display prominent actin stress fibers at the posterior region of the lamellipodium, as revealed by staining with phalloidin (Fig. 8D) . Exposure to kb NB 142-70 abolished the formation of these prominent arrays of actin stress fibers ( Fig. 8E) . Collectively, these results indicate that PKD1 signaling plays a critical role in the polarization of migrating epithelial cells.
Knockdown of PKD1 prevents wound-induced migration of intestinal epithelial cells. PKD1 is the founding member of the family of serine/threonine protein kinases that also includes PKD2 and PKD3 (47) . Although these kinases share similarities in overall structure and primary sequence (47) , recent studies reveal differences in the kinetics of their catalytic activation, subcellular distribution, and expression in different cell types (39, 41-43, 46, 47, 51) . Interestingly, global knockout of PRKD1 induces embryonic lethality in mice (13, 26) , while PKD2 and PKD3 cannot compensate for PKD1 depletion. To clarify the contribution of PKD1 in intestinal epithelial cell migration, we used siRNAs targeting this isoform of the PKD family. Recently, we verified that transient knockdown of PKD1 (by Ͼ85%) in IEC-18 cells did not alter the expression of PKD2 and, reciprocally, that knockdown of PKD2 did not alter the expression of PKD1, eliminating the possibility of compensatory changes in the expression of these PKD isoforms (51) . As shown in Fig. 9 , knockdown of PKD1 expression significantly inhibited the migration of IEC-18 cells into the denuded area of the wound. Similarly, knockdown of PKD1 with a different siRNA also prevented IEC-18 migration when wounding was performed by scratching the monolayer, rather than by removing an insert (Fig. 9) . These results further substantiate the notion that PKD1 plays a critical role in promoting migration of intestinal epithelial cells.
Overexpression of PKD1 augments migration of intestinal epithelial cells "in vivo." Collectively, our preceding results indicating that PKD1 is required for the migration of IEC-18 and IEC-6 cells prompted us to hypothesize that PKD1 pro- To test this hypothesis, we used transgenic mice that express elevated PKD1 protein in the small intestine epithelium (51) . As shown in Fig. 10A , the overexpression of PKD1 protein in the ileum was verified by Western blot analysis of total PKD1 in lysates of epithelial cells isolated sequentially along the crypt-villus axis by timed incubations in EDTA-PBS solutions (12, 24) . To measure the migration of intestinal epithelial cells in vivo, we intraperitoneally injected PKD1 transgenic mice and their nontransgenic littermates with the thymidine analog BrdU and determined enterocyte migration by measuring the distance from the bottom of the crypt to the foremost labeled enterocyte (2, 38) . The results (Fig. 10, B and C) demonstrate that enterocyte migration was markedly increased in the PKD1 transgenic mice compared with their nontransgenic littermates (P Ͻ 0.001). Because the crypts of PKD1 transgenic mice display increased depth compared with their controls (51), we verified a statistically significant increase in migration when the distance of the foremost BrdU-labeled enterocyte was divided by the length of the crypt (Fig. 10D) . The results support the hypothesis that PKD1 promotes the migration of intestinal epithelial cells in vivo.
DISCUSSION
Cell migration and proliferation in the GI mucosa play fundamental roles in homeostatic turnover, restoration of tissue integrity after injury, and pathogenesis of intestinal disorders, including inflammatory bowel disease and carcinogenesis. Despite their importance, the molecular mechanisms and crosstalk interactions controlling the proliferation and migration of intestinal epithelial cells remain incompletely understood. Our recent results implicated PKD1 in the control of proliferation of intestinal epithelial cells (51) . On the other hand, the role of PKD1 in cell migration remains incompletely understood, and the effect of breakdown of cell-cell contacts on PKD1 activity has not been examined in any cell type.
The present study demonstrates, for the first time, that wounding monolayer cultures of nontumorigenic IEC-18 and IEC-6 cells induces PKD1 phosphorylation at Ser 916 , an autophosphorylation site that has been used extensively to monitor PKD1 activation within intact cells (27, 50 -52) . A striking feature of our results is that PKD1 activation occurred rapidly, and it was restricted to the row of cells at the edge of the wound, suggesting that it results from the breakdown of cellcell contacts. Prior exposure of the monolayer to the preferential and structurally unrelated PKD family inhibitors kb NB 142-70 (22) and CRT0066101 (16) prevented the increase in PKD1 phosphorylation at Ser 916 , supporting the notion that wounding induces rapid PKD1 activation, leading to its autophosphorylation. This interpretation was further substantiated by using in vitro kinase assays after PKD1 immunoprecipitation. Collectively, the results demonstrate that wounding cultures of IEC-18 and IEC-6 cells induces PKD1 activation in cells possessing a free lateral surface, i.e., one that is not engaged in contact with neighboring cells. More experimental work is needed to determine whether such topographically restricted PKD1 activation in response to wounding is triggered by the release of a local mediator(s), breakdown of cell-cell contacts, which eliminates a contact-dependent signal that contributes to maintain PKD1 in an inhibited state of PKD1, or a combination of these mechanisms.
The rapid and striking increase in PKD1 activity detected in the intestinal epithelial cells at the edge of the wound raises the possibility that PKD1 signaling leads to the initiation of cell migration and wound healing. In agreement with this hypothesis, we found that inhibitors of PKD family activity, at concentrations that prevented wound-induced PKD1 activation, markedly slowed their ability to repopulate the denuded area of the monolayer. To elucidate the contribution of PKD1 in intestinal epithelial cell migration, we used siRNAs targeting this isoform of the PKD family. Knockdown of PKD1 expression significantly inhibited the migration of IEC-18 cells into the denuded area of the wound, although the inhibitory effect was less striking than that exerted by PKD family inhibition. It is plausible that other isoforms of the PKD family (i.e., PKD2 and PKD3) that are also inhibited by the smallmolecule inhibitors contribute to promote migration of IEC-18 cells. To test whether PKD1 promotes migration of intestinal epithelial cells in vivo, we used transgenic mice that express elevated PKD1 protein in the small intestine epithelium (51) . Enterocyte migration was determined by measuring the distance from the bottom of the crypt to the foremost labeled enterocyte (2, 38) . Our results demonstrated that enterocyte migration was markedly increased in the PKD1 transgenic mice compared with their nontransgenic littermates. Collectively, the results with cells and PKD1 transgenic mice demonstrate that PKD1 is a novel element that promotes migration in intestinal epithelial cells.
Migration of many cells is promoted by a sequence of processes involving the formation of protrusions driven by actin polymerization, establishment of cell polarization, adhesion to the substratum, cell body translocation, and rear retraction (45) . In agreement with our previous results (19), we show here that wounding of IEC-18 cells induced the formation of broad cell protrusions oriented toward the denuded area of the wound. These protrusions represent the "leading edge" of these cells migrating into the wound. The protrusions contained arrays of actin stress fibers orientated perpendicular to the free edge of the cells. Treatment with a PKD family inhibitor, at a concentration that abolished wound-induced PKD activation, prevented the formation of arrays of actin stress fibers and extensions oriented toward the denuded area of the monolayer and the repositioning of the nucleus to the rear of the cell, an index of polarization toward the empty space in migrating cells. Collectively, these results imply that PKD1 plays a key role in promoting the formation of the leading edge in epithelial cells. Recent studies indicate that net lamellipodium extension results from the balance between the rates of actin polymerization at the barbed ends and actin retrograde flow (31). We propose that PKD1 activity is necessary in intestinal epithelial cells to maintain the integrity of actin filaments at the rear of the lamellipodium, thereby preventing retrograde actin flow, which would counterbalance the growth of actin barbed ends needed for the formation of protrusions oriented toward the denuded area of the wound. In agreement with this proposal, several recent reports identified substrates of the PKD family that regulate actin dynamics via cofilin phosphorylation (10, 32) and Rho activation (35, 49) . Interestingly, we previously demonstrated that Rho activates PKD1 (64) , suggesting that Rho and PKD1 are part of an amplification loop that leads to actin stress fiber formation.
Consistent with the results presented here, PKD1 has been also implicated in the motility of fibroblasts (34, 61) , endothelial cells (11) , and prostate cancer cells (22, 63) and invasion of pancreatic cancer cells (30) . However, other studies concluded that PKD1 inhibits the motility of other cell lines, including HeLa and breast cancer cell lines (10, 32) . The complex spatiotemporal processes leading to cell migration are likely to depend on cell context and the migratory stimulus used, including chemotactic and haptotactic stimuli, breakdown of cell-cell contacts (as in this study), or combinations of any of these. It is plausible that PKD1 modulates cell migration through different mechanisms in different cell types, and the predominant pathway could depend on the migratory cue to which the cell responds.
PKD1, the most studied member of the PKD family, is implicated in the regulation of a remarkable array of fundamental biological processes, including signal transduction, cell proliferation and differentiation, membrane trafficking, hormone secretion, immune regulation, cardiac hypertrophy, angiogenesis, and cancer (reviewed in Refs. 46 and 47) . The migration of cells is a key aspect of many normal and abnormal biological processes, including embryonic development, defense against infections, wound healing, and tumor cell metastasis. On the basis of the results presented here, we conclude that PKD1 signaling plays a critical role in the regulation of migration of intestinal epithelial cells. , and E.R. edited and revised the manuscript; E.R. are responsible for conception and design of the research; E.R. approved the final version of the manuscript.
